COVID-19 treatment

September 17, 2020

Study finds COVID-19 antibodies drop substantially in the weeks following infection

The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).

By Nancy Humphrey
September 7, 2020

Possible key to COVID-19 infectivity

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.

By Sarah E. Glass
September 3, 2020

MPH students dive in to support COVID-19 response

Graduates from Vanderbilt’s Master in Public Health (MPH) program didn’t plan to become front-line soldiers against the COVID-19 global pandemic, but several have found themselves putting their training — and their career goals — front and center.

By Jake Lowary
David Haas, MD, and Beverly Woodward, MSN, RN, are shown in a procedure room in VUMC’s Communicable Disease Response Unit. The room contains state-of-the-art infection prevention features and opens directly to the outside.
September 2, 2020

VUMC launches clinical trial of outpatient treatments for COVID-19

Vanderbilt University Medical Center is now enrolling volunteers for a clinical trial of promising treatments for COVID-19 in the outpatient setting.

By Leigh MacMillan
August 27, 2020

Trial to test nasal irrigation to treat COVID

By Kelsey Herbers
July 29, 2020

Study finds patients defer routine health care during pandemic

During February and March at two large academic medical centers in Nashville and Boston, screening for high cholesterol and high blood sugar dropped 81-90% and initiation of drug therapy for these conditions dropped 52-60%.

By Paul Govern
July 22, 2020

Study to explore how COVID affects cognition over time

The Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University Medical Center is following patients who have been hospitalized for COVID-19 over time to see if they develop long-term cognitive impairment, depression or post-traumatic stress disorder (PTSD).
By Nancy Humphrey
July 22, 2020

New data offer insights on COVID treatments for people with cancer

Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.
By Tom Wilemon
July 16, 2020

Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients

Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
By VUMC News and Communications
July 15, 2020

Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19

Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.
By Bill Snyder
July 15, 2020

Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial

In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
By Bill Snyder
July 9, 2020

New study supports remdesivir as COVID-19 treatment

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.
By Bill Snyder
July 9, 2020

Coordinated care network ensures COVID-positive patient makes recovery

On March 27, Nashville resident Bill Boyce, 73, earned the unwelcome distinction of becoming the first patient intubated on Vanderbilt University Medical Center’s dedicated COVID-19 unit.
By Jill Clendening
1 … 6 7 8 9 10 … 12